ATE444739T1 - Polymerzusammensetzung sowie diese enthaltende darreichungsformen - Google Patents
Polymerzusammensetzung sowie diese enthaltende darreichungsformenInfo
- Publication number
- ATE444739T1 ATE444739T1 AT03714356T AT03714356T ATE444739T1 AT E444739 T1 ATE444739 T1 AT E444739T1 AT 03714356 T AT03714356 T AT 03714356T AT 03714356 T AT03714356 T AT 03714356T AT E444739 T1 ATE444739 T1 AT E444739T1
- Authority
- AT
- Austria
- Prior art keywords
- dosage forms
- polymer composition
- forms containing
- containing same
- dosage form
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 229920000642 polymer Polymers 0.000 title abstract 2
- 239000011159 matrix material Substances 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2002/031062 WO2003026626A2 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
| PCT/US2002/031117 WO2003026629A2 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
| PCT/US2002/031024 WO2003026625A1 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
| PCT/US2002/031163 WO2003026627A1 (en) | 2001-09-28 | 2002-09-28 | Composite dosage forms |
| PCT/US2002/031129 WO2003026630A1 (en) | 2001-09-28 | 2002-09-28 | Dosage forms having an inner core and outer shell with different shapes |
| PCT/US2003/008960 WO2004028514A1 (en) | 2002-09-28 | 2003-03-21 | Polymer composition and dosage forms comprising the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE444739T1 true ATE444739T1 (de) | 2009-10-15 |
Family
ID=34271652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03714356T ATE444739T1 (de) | 2002-09-28 | 2003-03-21 | Polymerzusammensetzung sowie diese enthaltende darreichungsformen |
Country Status (8)
| Country | Link |
|---|---|
| JP (3) | JP2006517514A (de) |
| CN (3) | CN1700907A (de) |
| AT (1) | ATE444739T1 (de) |
| AU (4) | AU2003220472A1 (de) |
| BR (5) | BR0314781A (de) |
| CA (3) | CA2500311A1 (de) |
| DE (2) | DE60335270D1 (de) |
| MX (1) | MXPA05003283A (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2470463C (en) | 2004-06-09 | 2012-09-18 | Lornamead Brands, Inc. | Tooth whitening products and methods of making the same |
| SA07280459B1 (ar) * | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
| WO2009153635A1 (en) * | 2008-06-19 | 2009-12-23 | University Of Witwatersrand, Johannesburg | A chronotherapeutic pharmaceutical dosage form |
| JPWO2011118454A1 (ja) * | 2010-03-23 | 2013-07-04 | リンテック株式会社 | 固形製剤 |
| WO2013009701A2 (en) * | 2011-07-08 | 2013-01-17 | The University Of North Carolina At Chapel Hill | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
| BR112014019526B8 (pt) * | 2012-02-07 | 2022-08-30 | Chenango Zero Llc | Forma de dosagem de liberação rápida e seu método de produção |
| TW201400146A (zh) * | 2012-06-05 | 2014-01-01 | Takeda Pharmaceutical | 有核錠 |
| EP3193845A1 (de) * | 2014-09-19 | 2017-07-26 | The Procter and Gamble Company | Darreichungsformen von phenylephrin mit gepulster freisetzung |
| EP3727384A4 (de) | 2017-12-20 | 2021-11-03 | Purdue Pharma L.P. | Missbrauchshemmende darreichungsformen von morphinsulfat |
| MX2020006886A (es) * | 2017-12-29 | 2020-11-11 | Laxxon Medical Ag | Sistema para suministro de medicamento. |
| BR112024001927A2 (pt) * | 2021-07-30 | 2024-04-30 | Evecxia Therapeutics Inc | Formas de dosagem gastrorretentivas de 5-hidroxitriptofano |
| US12409163B2 (en) | 2021-07-30 | 2025-09-09 | Evecxia Therapeutics, Inc. | Method of enhancing 5-hydroxytryptophan (5-HTP) exposure |
| CN115295864B (zh) * | 2021-11-09 | 2023-08-11 | 深圳市德方创域新能源科技有限公司 | 正极补锂添加剂及其制备方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994007470A1 (en) * | 1992-09-30 | 1994-04-14 | Pfizer Inc. | Article containing a core and a coating having a non constant thickness |
| GB9402203D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Pharmaceutical formulation |
| DE4431653C2 (de) * | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung |
| IT1282576B1 (it) * | 1996-02-06 | 1998-03-31 | Jagotec Ag | Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili |
| US6602521B1 (en) * | 1998-09-29 | 2003-08-05 | Impax Pharmaceuticals, Inc. | Multiplex drug delivery system suitable for oral administration |
| EP1275373A4 (de) * | 2000-04-17 | 2007-04-04 | Astellas Pharma Inc | Arzneistoffabgabesystem zur vermeidung von pharmakokinetischen wechselwirkungen zwischen wirkstoffen und methode hierzu |
| JP2004518709A (ja) * | 2001-02-13 | 2004-06-24 | アストラゼネカ・アクチエボラーグ | 新規放出修飾製剤 |
-
2003
- 2003-03-21 AU AU2003220472A patent/AU2003220472A1/en not_active Abandoned
- 2003-03-21 CN CN03825324.0A patent/CN1700907A/zh active Pending
- 2003-03-21 BR BR0314781-9A patent/BR0314781A/pt not_active Application Discontinuation
- 2003-03-21 DE DE60335270T patent/DE60335270D1/de not_active Expired - Lifetime
- 2003-03-21 JP JP2004539767A patent/JP2006517514A/ja active Pending
- 2003-03-21 CA CA002500311A patent/CA2500311A1/en not_active Abandoned
- 2003-03-21 BR BR0314777-0A patent/BR0314777A/pt not_active Application Discontinuation
- 2003-03-21 CN CN03825331.3A patent/CN1700908A/zh active Pending
- 2003-03-21 JP JP2004539770A patent/JP2006517183A/ja active Pending
- 2003-03-21 BR BR0314787-8A patent/BR0314787A/pt not_active IP Right Cessation
- 2003-03-21 CA CA002500312A patent/CA2500312A1/en not_active Abandoned
- 2003-03-21 AT AT03714356T patent/ATE444739T1/de not_active IP Right Cessation
- 2003-03-21 CA CA2500313A patent/CA2500313C/en not_active Expired - Fee Related
- 2003-03-21 MX MXPA05003283A patent/MXPA05003283A/es unknown
- 2003-03-21 CN CN03823065.8A patent/CN1684671A/zh active Pending
- 2003-03-21 AU AU2003220466A patent/AU2003220466A1/en not_active Abandoned
- 2003-03-21 BR BR0314804-1A patent/BR0314804A/pt not_active Application Discontinuation
- 2003-03-21 AU AU2003225944A patent/AU2003225944A1/en not_active Abandoned
- 2003-03-21 DE DE60329614T patent/DE60329614D1/de not_active Expired - Lifetime
- 2003-03-21 JP JP2004539769A patent/JP2006517182A/ja active Pending
- 2003-03-21 BR BR0314547-6A patent/BR0314547A/pt not_active Application Discontinuation
- 2003-03-21 AU AU2003218359A patent/AU2003218359A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2500313A1 (en) | 2004-04-08 |
| CA2500311A1 (en) | 2004-04-08 |
| CA2500312A1 (en) | 2004-04-08 |
| BR0314787A (pt) | 2005-07-26 |
| BR0314777A (pt) | 2005-07-26 |
| CN1684671A (zh) | 2005-10-19 |
| AU2003225944A1 (en) | 2004-04-19 |
| MXPA05003283A (es) | 2005-11-23 |
| BR0314804A (pt) | 2005-08-02 |
| AU2003220466A1 (en) | 2004-04-19 |
| JP2006517182A (ja) | 2006-07-20 |
| BR0314781A (pt) | 2005-07-26 |
| DE60329614D1 (de) | 2009-11-19 |
| CA2500313C (en) | 2011-06-07 |
| JP2006517183A (ja) | 2006-07-20 |
| JP2006517514A (ja) | 2006-07-27 |
| CN1700908A (zh) | 2005-11-23 |
| CN1700907A (zh) | 2005-11-23 |
| AU2003220472A1 (en) | 2004-04-19 |
| DE60335270D1 (de) | 2011-01-20 |
| BR0314547A (pt) | 2005-08-09 |
| AU2003218359A1 (en) | 2004-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE355829T1 (de) | Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung | |
| AU2003231126A1 (en) | Chewable soft capsule | |
| BRPI0500704A (pt) | composições de tratamento pessoal reidratáveis | |
| ATE444739T1 (de) | Polymerzusammensetzung sowie diese enthaltende darreichungsformen | |
| ATE288256T1 (de) | Dermale zusammensetzungen | |
| SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
| BR0113663A (pt) | Composições de pelìcula de pectina | |
| BRPI0407882A (pt) | conjugados de polìmero-porção de fator viii | |
| WO2003032953A1 (en) | Granules containing acid-unstable chemical in large amount | |
| BR0214279A (pt) | Composições farmacêuticas em forma particulada | |
| BR0206441A (pt) | Composição de revestimento de pelìcula, revestimento de pelìcula cobrindo um núcleo farmacêutico, formulação farmacêutica de liberação modificada, e, processos para preparar uma composição de revestimento de pelìcula, um revestimento de pelìcula e uma formulação | |
| AU2003275958A1 (en) | Muteins of tear lipocalin | |
| DK1162943T3 (da) | Ikke-sviende coatingpræparat | |
| AR011116A1 (es) | Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene | |
| ES2176502T3 (es) | Derivados de hidroxilamina utiles para mejorar la pproduccion de chaperonas moleculares su su preparacion. | |
| WO2004010941A3 (en) | Aqueous 2,6-diisopropylphenol pharmaceutical compositions | |
| SE0201659D0 (sv) | Modified release pharmaceutical formulation | |
| CO5440227A1 (es) | Composicion antihelmitica e inyectable mejorada de crecimiento | |
| SE0401970D0 (sv) | Novel compounds | |
| SE0302573D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| ATE478662T1 (de) | Arzneilösungen enthaltend modafinilverbindungen | |
| FI20095606A7 (fi) | Järjestelmä ja menetelmä alhaisen suspendoituneen kiintoainepitoisuuden omaavan liuoksen tuottamiseksi ja sellaisen liuoksen käyttö | |
| ECSP055566A (es) | Formulaciones de depósito de corta duración | |
| SE0302570D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| DE60208528D1 (de) | Hochsulfatierte derivate von k5-polysacchariden und ihre herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |